NAFPENZAL DC (300+100+100)MG/3G ΕΝΔΟΜΑΣΤΙΚΟ ΕΝΑΙΩΡΗΜΑ
NAFPENZAL DC (300+100+100)MG/3G ΕΝΔΟΜΑΣΤΙΚΟ ΕΝΑΙΩΡΗΜΑ
Authorised
- Benzylpenicillin procaine
- Nafcillin sodium monohydrate
- Dihydrostreptomycin sulfate
Product identification
Medicine name:
NAFPENZAL DC (300+100+100)MG/3G ΕΝΔΟΜΑΣΤΙΚΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
- Benzylpenicillin procaine
- Nafcillin sodium monohydrate
- Dihydrostreptomycin sulfate
Target species:
-
Goat
-
Cattle
-
Sheep
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Benzylpenicillin procaine300.00milligram(s)3.00gram(s)
-
Nafcillin sodium monohydrate100.00milligram(s)3.00gram(s)
-
Dihydrostreptomycin sulfate100.00milligram(s)3.00gram(s)
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Goat
-
Meat and offal35day
-
Milk9day
-
- Cattle
-
Meat and offal16day
-
Milk48hour
-
- Sheep
-
Meat and offal35day
-
Milk5day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51GA90
- QJ51RC
- QJ51RC22
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 18132/09-03-2009/K-0112802
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: